Ultrasound and tissue checks for early endometrial cancer treated conservatively
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether combining ultrasound with tissue samples can better monitor women with early-stage endometrial cancer or precancer who choose fertility-sparing treatment instead of hysterectomy. It may help preserve your ability to have children while closely tracking the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 45 years old.
- You have been diagnosed with atypical endometrial hyperplasia (AEH) or a low-grade (G1-2) endometrioid endometrial cancer.
- You want to keep the option to have children in the future and are willing to try fertility-sparing treatments like hysteroscopic surgery or progesterone therapy.
- You have not had invasive endometrial cancer before.
- You can have a clear view of your uterus using a vaginal ultrasound or MRI.
- You do not have any condition that makes hormone therapy unsafe (like blood clots) and are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at small lab samples taken from early endometrial cancer to see how sensitive the tumor is to progesterone treatment. It may help doctors choose the safest treatment that preserves fertility and the uterus for the right patients.
This study looks at whether a hormone-releasing IUD (LNG-IUS) can treat early-stage endometrial cancer or very early abnormal cell growth while helping you keep the option for future pregnancy. It aims to see how well the treatment works and how it affects fertility-related outcomes.
This study tests whether a simple vaginal fluid sample can help detect endometrial cancer (cancer of the uterus lining) or precancerous changes. You'll provide a vaginal specimen alongside your standard medical care, helping researchers develop a non-invasive screening tool.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study looks at women with endometrial adenocarcinoma or atypical hyperplasia who had conservative treatment instead of radical surgery. It aims to check how well the treatment works for both cancer and future pregnancy outcomes.
This trial studies whether removing an early, hormone-responsive uterine growth using a procedure through the cervix can keep fertility possible. It is for people under 40 with a specific low-risk uterine biopsy and MRI findings who have already tried hormone treatment.
Hear when a new Atypical Endometrial Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.